ArticleDermatologie (Heidelberg, Germany)2026
[Clinical aspects and diagnostics of mast cell-mediated angioedemas].
Article in Dermatologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Angioedema is defined as transient swelling of the skin and/or mucous membranes. Based on the underlying mediator, angioedema is essentially classified as either mast cell-mediated or bradykinin-mediated. In general, mast cell-mediated angioedema is of shorter duration (1-3 days) and responds to antihistamines, corticosteroids and adrenaline, whereas swelling associated with bradykinin-mediated angioedema typically persists longer and does not respond to histamine-targeted drugs. Mast cell-mediated angioedema includes swelling occurring as part of allergic (IgE-mediated) or pseudoallergic (non-IgE-mediated) reactions, such as those observed in anaphylaxis or intolerance to analgesics. The diagnostic evaluation comprises a detailed medical history, measurement of specific IgE antibodies and/or skin prick testing, as well as provocation testing when indicated. Mast cell-mediated angioedema frequently occurs in association with chronic spontaneous urticaria (CSU), in which approximately 10% of patients can present with isolated angioedema without wheals as well as with chronic inducible urticaria (CIndU). The diagnostic work-up follows current recommendations for chronic urticaria and includes a thorough medical history, physical examination (potentially supported by review of photographic documentation) and basic laboratory investigations, including a differential blood count, C‑reactive protein (CRP), total IgE, and IgG anti-thyroid peroxidase (anti-TPO) antibodies. In the routine clinical practice, in both emergency settings and during the elective evaluation of patients with angioedema, it is essential to be familiar with the characteristic clinical features, differential diagnoses and diagnostic approaches of the various forms of mast cell-mediated angioedema.
Indexed as
Identifiers
42536119What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.